Organon & Co | Renteudgifter På Gæld



Interest Expense On Debt Lave om Dato
Bristol-Myers Squibb USD 496M 9M 2024-12
Celltrion KRW 18.38B 907.05M 2024-09
Cspc Pharmaceutical 11.32M 4.55M 2024-09
Dianthus Therapeutics 4.44M 4.44M 2024-09
Ecofibre AUD 761K 773K 2024-06
Gilead Sciences USD 248M 10M 2024-12
Glaxosmithkline 178.05M 24.73M 2024-12
Kangmei Pharma CNY 3.12M 140.6K 2023-09
Knight Therapeutics CAD 1.91M 369K 2024-09
Medical Developments International AUD 21K 23K 2024-06
Merck USD 328M 2M 2024-12
Neuren Pharmaceuticals 0 0 2024-06
Novartis USD 275M 11M 2024-12
Organon & Co USD 132M 6M 2024-12
Qiagen NV USD 11.14M 337K 2024-12
Sartorius 48.9M 41.76M 2024-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Tilray USD 7.77M 2.08M 2024-11



Organon & Co Renteudgifter På Gæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.